biospecimen__admin__batch_number	203.73.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	4B7C63EE-286C-473A-8371-7385E783D118
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-BC-A3KG-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-BC-A3KG-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-BC-A3KG-01A
biospecimen__bio__biospecimen_barcode_bottom	0122967822
biospecimen__bio__day_of_creation	30
biospecimen__bio__day_of_shipment	24
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	12
biospecimen__bio__month_of_shipment	01
biospecimen__bio__pathology_report_file_name	TCGA-BC-A3KG.67A81454-06A8-451D-B855-F9D146CC0348.pdf
biospecimen__bio__plate_column	7
biospecimen__bio__plate_id	A214
biospecimen__bio__plate_row	B
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	3.20
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2011
biospecimen__bio__year_of_shipment	2012
biospecimen__shared__bcr_patient_barcode	TCGA-BC-A3KG
biospecimen__shared__patient_id	A3KG
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	1F0D5DD6-1497-467E-BEBB-85B7BB7324F7
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.5
clinical__chol_lihc_shared__albumin_result_specified_value	3.6
clinical__chol_lihc_shared__albumin_result_upper_limit	5.0
clinical__chol_lihc_shared__bilirubin_lower_limit	0.0
clinical__chol_lihc_shared__bilirubin_upper_limit	0.5
clinical__chol_lihc_shared__creatinine_lower_level	0.6
clinical__chol_lihc_shared__creatinine_upper_limit	1.0
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.7
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	10
clinical__chol_lihc_shared__fetoprotein_outcome_value	618
clinical__chol_lihc_shared__hist_hepato_carc_fact	Alcohol consumption
clinical__chol_lihc_shared__platelet_result_lower_limit	150000
clinical__chol_lihc_shared__platelet_result_upper_limit	440000
clinical__chol_lihc_shared__prothrombin_time_result_value	1.1
clinical__chol_lihc_shared__specimen_collection_method_name	Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.2
clinical__chol_lihc_shared__vascular_tumor_cell_type	Micro
clinical__clin_shared__age_at_initial_pathologic_diagnosis	68
clinical__clin_shared__bcr_followup_barcode	TCGA-BC-A3KG-F38205
clinical__clin_shared__bcr_followup_uuid	59B40341-161E-4C90-A8CE-1E662C079D82
clinical__clin_shared__day_of_form_completion	11
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	4
clinical__clin_shared__person_neoplasm_cancer_status	WITH TUMOR
clinical__clin_shared__platelet_result_count	499000
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	NO
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	YES
clinical__clin_shared__tissue_retrospective_collection_indicator	NO
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__year_of_form_completion	2012
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2011
clinical__lihc_nte__new_tumor_event_liver_transplant	No
clinical__nte__additional_pharmaceutical_therapy	YES
clinical__nte__days_to_new_tumor_event_after_initial_treatment	209
clinical__nte__new_neoplasm_event_occurrence_anatomic_site	Other, specify
clinical__nte__new_neoplasm_event_type	Extrahepatic Recurrence
clinical__nte__new_neoplasm_occurrence_anatomic_site_text	Spleen
clinical__nte__new_tumor_event_additional_surgery_procedure	NO
clinical__nte__new_tumor_event_after_initial_treatment	YES
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G3
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T2
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	83f071ae-c4d2-4268-9fc0-cb81d939540c
gdc__aliquots__concentration	0.16
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-BC-A3KG-01A-11R-A214-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	df0be95a-350a-4a86-a95d-0d286d362c25
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.66
gdc__analytes__analyte_id	ab305211-baef-42f3-819d-2ae879f4e81f
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	75f43fca-200a-48b0-bb67-0693d7b91119
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:49:30.029218-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	b07159a5-c041-5962-aaf7-ff8f9b7889d3
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	female
gdc__demographic__race	white
gdc__demographic__year_of_birth	1943
gdc__diagnoses__age_at_diagnosis	25061
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-25061.0
gdc__diagnoses__days_to_last_follow_up	680.0
gdc__diagnoses__diagnosis_id	3301db0f-ac03-5bd1-bd3f-b4373b1bcb4c
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage ii
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	25.315454293738377
gdc__exposures__exposure_id	09b05597-0b18-5fc0-9f45-0521ce775222
gdc__exposures__height	159.0
gdc__exposures__weight	64.0
gdc__file_id	0a4e1dee-7bb9-4b06-be75-102a6303cc67
gdc__file_name	c09b4cf3-f097-4ab0-9058-6887326ee3c6.mirbase21.mirnas.quantification.txt
gdc__file_size	50484
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	78c1eb04299c135e6ddf3e6f5ef203a1
gdc__portions__is_ffpe	false
gdc__portions__portion_id	c0e9d392-4a7c-468a-84a6-699c5d4ef672
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	140
gdc__samples__initial_weight	790.0
gdc__samples__oct_embedded	false
gdc__samples__pathology_report_uuid	67A81454-06A8-451D-B855-F9D146CC0348
gdc__samples__sample_id	da632ff7-e6b4-4ecd-ab72-a08461588b44
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	0.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	0.0
gdc__slides__percent_tumor_cells	100.0
gdc__slides__percent_tumor_nuclei	95.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	c61dd820-9673-4de8-9952-4433dae17450
gdc__submitter_id	mirna_swap_dr11_398_MirnaExpression215e3d31-907d-4fa0-9694-353451af9b91_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	BC
gdc__tissue_source_site__name	UNC
gdc__tissue_source_site__tissue_source_site_id	735fda57-1a46-5afd-a1c0-99af9115c0af
gdc__treatments__treatment_id	d3fbd640-1d6d-5287-a86a-ad048e4d6193
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:09:46.271+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/83f071ae-c4d2-4268-9fc0-cb81d939540c-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/83f071ae-c4d2-4268-9fc0-cb81d939540c-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129855
manually_curated__local_md5	f44a8d05146c28e3a47adf9a44e8bf4c
manually_curated__opengdc_download_date	2018-10-16T17:11:44.000248+02:00
manually_curated__opengdc_file_md5	ee5747cb9cce6494ec4f698d9d735912
manually_curated__opengdc_file_size	50483
manually_curated__opengdc_id	83f071ae-c4d2-4268-9fc0-cb81d939540c-meq
manually_curated__origin_file_size	129855
manually_curated__origin_last_modified_date	Tue Oct 16 17:51:00 CEST 2018
manually_curated__origin_md5	f44a8d05146c28e3a47adf9a44e8bf4c
manually_curated__tissue_status	tumoral
